6533b825fe1ef96bd1282618

RESEARCH PRODUCT

KRAS and BRAF as prognostic biomarkers in patients undergoing surgical resection of colorectal cancer liver metastasis: A systematic review and meta-analysis.

Giuseppe BronteGiuseppe CiceroFrancesco PassigliaEmmanuela MussoAntonio RussoA. GuariniSalvatore VieniValentina CalòSergio RizzoL. CastellanaChristian RolfoNadia BarracoR. MaraglianoL. InsalacoAngela ListìViviana BazanMarta CastigliaEnrico BronteAntonio Galvano

subject

OncologySurgical resectionCancer Researchmedicine.medical_specialtyendocrine system diseasesColorectal cancerbusiness.industrymedicine.diseasemedicine.disease_causedigestive system diseasesMetastasisClinical trialOncologyInternal medicineMeta-analysismedicineIn patientKRASbusinessSurgical treatmentneoplasms

description

3565Background: Clinical trials investigated the potential role of both KRAS and BRAF mutations, as prognostic biomarkers, in colorectal cancer (CRC) patients who underwent surgical treatment of li...

https://doi.org/10.1200/jco.2016.34.15_suppl.3565